Horizon Therapeutics Plc

( )
HZNP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.05%163.300.7%$1331.47m
LLYEli Lilly & Co. 0.74%324.001.1%$1075.83m
ABBVAbbVie, Inc. 0.86%139.491.9%$859.47m
PFEPfizer Inc. 0.52%44.340.9%$801.77m
BMYBristol-Myers Squibb Co. -0.03%70.521.0%$772.56m
MRKMerck & Co., Inc. 0.32%87.840.7%$712.72m
AZNAstraZeneca Plc 1.73%56.511.0%$394.19m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%196.798.2%$217.39m
GSKGSK Plc 1.95%30.820.3%$213.60m
NVSNovartis AG 1.81%78.060.2%$205.31m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.485.4%$191.16m
IDXXIDEXX Laboratories, Inc. 1.12%340.463.9%$186.35m
ATXIAvenue Therapeutics, Inc. 28.76%14.820.0%$179.37m
HZNPHorizon Therapeutics Plc 0.00%64.265.4%$173.65m
SRPTSarepta Therapeutics, Inc. 0.00%109.9412.4%$136.73m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engaged in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.